Home » Topics » BioWorld Science

BioWorld Science
RSS

Global collaboration to develop first-in-class gene therapy for cystic fibrosis

Aug. 6, 2018

Potential mechanism of purinergic receptor-mediated remyelination discovered

Aug. 6, 2018

DrugCendR recruiting participants for phase I study of CEND-1 in metastatic pancreatic cancer

Aug. 6, 2018

IL-23 underlies the development of castration-resistant prostate cancer

Aug. 6, 2018

Immatics begins phase I study of IMA-202 in solid tumors

Aug. 6, 2018

Salix enters microbiome collaboration with Cedars-Sinai Medical Center

Aug. 6, 2018

HitGen to identify potential new therapies for tuberculosis and malaria

Aug. 6, 2018

JCR Pharmaceuticals presents data for JR-141 in mucopolysaccharidosis type II

Aug. 6, 2018

Neurodegenerative differences found between the presubiculum and entorhinal cortex in AD

Aug. 6, 2018

Medicenna's IL-2 superkine shows promising preclinical activity

Aug. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...